Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Total Debt Over TimeFair Value
Percentile Rank33
3Y CAGR-2.5%
5Y CAGR-16.4%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
-2.5%/yr
Annual compound
5Y CAGR
-16.4%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineFair Value
PeriodValueYoY Change
2024$1.51M-24.2%
2023$2.00M-17.3%
2022$2.41M+47.9%
2021$1.63M+26.5%
2020$1.29M-65.2%
2019$3.71M+440.3%
2018$686545.00-